Global Musculoskeletal Drugs Market 2011-2015
TechNavio's analysts forecast the Global Musculoskeletal Drugs market to grow at a CAGR of 14.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of musculoskeletal diseases. The Global Musculoskeletal Drugs market has also been witnessing the increasing use of drugs for treatment of multiple diseases. However, the upcoming patent expiries of top-selling drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Musculoskeletal Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Musculoskeletal Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Abbott Laboratories Inc., Eli Lilly and Co., Johnson and Johnson Services Inc., and Pfizer Inc.
Key questions answered in this report:
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
Table of Contents
Table of Contents:
01. Executive Summary
03. Market Coverage
04. Market Landscape
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Pfizer Inc.
15.2 Abbott Laboratories Inc.
15.3 Eli Lilly and Co.
15.4 Johnson & Johnson Services Inc.
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Musculoskeletal Drugs Market 2011-2015 (US$ billion)
Exhibit 2: Global Musculoskeletal Drugs Market Segmentation by Drug Use 2011
Exhibit 3: Global Musculoskeletal Drugs market by Geographical Segmentation 2011
Exhibit 4: Global Musculoskeletal Drugs market by Vendor Segmentation 2011
Published May 21, 2012